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Abstract  
One half of pregnancies in the United States are 
unintended and associated with adverse 
pregnancy outcomes. The postpartum period is 
an important, yet underutilized, time to initiate 
contraception. The U.S. Medical Eligibility 
Criteria for Contraceptive Use, 2010 provides 
evidence-based guidelines for choosing a 
contraceptive method and an update in 2011 
specifically addresses contraceptive method use 
in the puerperium. The variety of contraceptive 
methods include hormonal contraception, 
lactational amenorrhea, barrier contraception, 
natural family planning, and sterilization. Ideally, 
counseling about contraceptive choice should 
begin early in pregnancy care and continue 
postpartum; it should also include a variety of 
teaching modalities. Specifically we recommend 
LARC options such as intrauterine devices and 
etonorgestrel implants, postpartum tubal 
sterilization, and progestin-only pills for those 
desiring an oral method. 
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Data from the United States reveals that 
of the approximately 6.6 million 
pregnancies per year, one-half are 
unintended.1-3  Of the approximately 61 
million women of reproductive age in 
2006-2010, 62% were using some form 
of contraception.4  7.7% of those not 
using contraception had intercourse in 
the previous 3 months, and represent 
those at highest risk for unintended 
pregnancy.5  Unintended pregnancies 
are associated with adverse pregnancy 
outcomes and behaviors, including late 
entry into prenatal care, decreased 
breastfeeding, and low birth weight.6  
Also, short interval pregnancies are at 
increased risk for obstetric 
complications, including low birth 
weight, preterm birth and neonatal 
mortality.7-9  The optimal interval 
between pregnancies is debated, but 
greater than 11-18 months has been 
suggested as reducing complications in 
the subsequent pregnancy.7,8  
Postpartum contraception is vital to the 
reduction of short interval pregnancies, 
which is a significant source of neonatal 
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morbidity and medical care costs. 
The immediate puerperium is an 
important period to initiate 
contraception.10 Women are often 
motivated to prevent or delay another 
pregnancy, they have immediate access 
to health care providers, and they are 
known not be pregnant.10,11  Because 
ovulation may occur as early as 25 days 
postpartum among women not 
breastfeeding, providing an effective 
contraceptive method during the 
puerperium is vitally important in 
reducing unintended pregnancy.12 
The puerperium is a unique time period 
in a woman’s life, resulting in unique 
contraception needs.  Understanding 
and communicating the risks and 
benefits of the various contraceptive 
methods is vital, as some contraceptive 
forms are better suited than others for 
use during this time period. 
In 2010, the Centers for Disease Control 
(CDC) published U.S. Medical Eligibility 
Criteria for Contraceptive Use, 2010 (US 
MEC),13 providing evidence-based 
guidelines for choosing a contraceptive 
method based on the relative safety for 
women with certain 
characteristics/conditions, including 
those who are postpartum.  A category 
1 distinction indicates that there are no 
restrictions for the use of a particular 
contraceptive method. Category 2 
designates that the method may be 
used but that individualization and 
careful follow-up may be required.  
Category 3 indicates that a certain 
method is generally not recommended 
unless other methods are unavailable or 
unacceptable.  Category 4 notes an 
unacceptable health risk may be 
conferred with use.13   The CDC-MEC 
criteria can be used to evaluate options 
for women in the postpartum period with 
and without chronic medical conditions.  
Updates to the CDC-MEC 
recommendations specific for 
postpartum women were released in 
2011 and will be reviewed here. 
Hormonal contraception 
Combined estrogen and progestin 
hormonal contraceptive agents (oral 
combined hormonal contraceptive 
pills, transdermal patch, vaginal ring) 
 
Hormonal contraceptives are among the 
most used methods of contraception in 
the United States.  In fact, according to 
the most recent data from the National 
Center for Health Statistics, the oral 
contraceptive pill is used by 17.1% of all 
reproductive age women (28% of 
women using some form of 
contraception), 1.3% use the 
contraceptive ring, and 0.9%, the 
implant or transdermal patch.5 These 
methods prevent ovulation by 
suppressing hypothalamic 
gonadotropin-releasing factors, which 
then prevents pituitary secretion of FSH 
and LH.  Estrogens prevent ovulation by 
suppressing FSH release, and also 
stabilize the endometrium.  Progestins 
suppress LH, thicken cervical mucus, 
and render the endometrium 
unfavorable for implantation.14  Oral 
progestin-only options can provide 
contraceptive efficacy, although the 
estrogen component improves cycle 
control, unfortunately at the expense of 
estrogenic side effects such as nausea, 
breast tenderness and thromboembolic 
events.15 Progestins produce 
androgenic side effects such as acne, 
hirsutism and lipid changes.15  The 
overall side effect profile, therefore, is 
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dependent upon the concentration of 
each hormone and specific type of 
progestin.15 
Combined hormonal contraceptive pills 
have many benefits, including familiarity 
with the method, effectiveness, safety, 
reversibility, cycle control, decrease in 
dysmenorrhea, decrease in days of 
bleeding and amount of blood loss and 
other, non-contraceptive benefits.16 
Non-oral delivery methods such as the 
transdermal patch or vaginal ring have 
the additional advantage of eliminating 
the need for daily compliance, as well as 
offering a different pharmacokinetic 
profile.15  Daily intake of oral combined 
hormonal contraceptives creates peaks 
and troughs in ethinyl estradiol 
concentrations, whereas the ring and 
patch deliver more constant levels.  
Exposure is lowest with the ring, while 
the patch is associated with the greatest 
overall exposure.15  Intermenstrual 
bleeding, amenorrhea, breast 
tenderness, abdominal bloating, 
headache and nausea are a few of the 
common side effects of combined oral 
contraceptives.  The transdermal patch 
has similar side effects, though breast 
discomfort and dysmenorrhea are 
significantly more common.  The most 
frequent side effects associated with the 
vaginal ring are headache, leukorrhea, 
vaginitis, weight gain and nausea.15   
Despite the advantages, there are 
several reasons why combined 
hormonal contraceptives are not 
typically used in the puerperium. The 
safety and timing of contraceptive 
initiation during lactation are subject to 
debate.  Studies of hormonal 
contraceptive agents with doses of 
ethinyl estradiol or mestranol of 50 mcg 
or more have demonstrated a 
suppressive effect on lactation.  Those 
with 35 mcg or less, still have some 
suppressive effects, and low-dose 
combination oral contraceptives 
containing 0.03 mg ethinyl estradiol and 
0.15 mg levonorgestrel in women who 
had been nursing for one month, had a 
small but significant decrease in 
lactation performance and in weight gain 
of their infants17 or cause maternal 
anxiety about milk supply.  This slight 
inhibition of lactation induced by 
combined oral contraceptive agents may 
be sufficient enough to discourage 
women from continuing breastfeeding, 
particularly in those whose desire to 
nurse is marginal.17  On the other hand, 
a 2003 Cochrane review concluded that 
there was insufficient evidence to 
establish the effect of combined 
hormonal contraceptives, if any, on milk 
quality or quantity18 and a systematic 
review confirmed an inconsistent effect 
of combined oral contraceptives on 
breastfeeding duration and success, 
and found that infant outcomes were not 
affected.19   
An update to the US MEC, specifically 
regarding use of contraceptive methods 
during the postpartum period, was 
published in 2011.11  These updated 
recommendations describe specific 
guidelines stating that all postpartum 
women should not use combined 
hormonal contraceptives during the first 
21 days postpartum due to significant 
increased risk of venous 
thromboembolism (VTE) (category 4).  
During days 21-42, non-breastfeeding 
women with risk factors for VTE (e.g. 
prior VTE, recent cesarean delivery, or 
smoking), should not use these methods 
for the same reason of increased VTE 
risk (category 3).  Without additional risk 
factors for VTE, use of combined 
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hormonal contraceptive during days 21-
42 is category 2, thus acceptable.  After 
42 days postpartum, no exceptions 
apply and use of combined hormonal 
contraceptives for all non-breastfeeding 
women is category 1.  In breastfeeding 
postpartum women, from 21 days to < 
30, regardless of the presence of 
additional risk factors for VTE, use is 
category 3.  Without additional risk 
factors for VTE, use of combined 
hormonal contraceptive from day 30 
forward, is category 2.11 (see table 1) 
Since ovulation is unlikely in the first 
month after delivery, women can be 
provided with a prescription for 
combined hormonal contraception to 
begin at one month (30 days from 
delivery).  
Progestogen-only contraceptives 
(progestin-only oral contraceptive 
pills, injectables) 
 
Progestogen-only hormonal methods, 
including progestin-only pills and depot 
medroxyprogesterone acetate (DMPA) 
injections have long been recommended 
as an alternative to combined hormonal 
contraceptives in the postpartum period.  
They are safe for postpartum women, 
including women who are breastfeeding, 
and can be initiated immediately 
postpartum (categories 1 and 2)11 (see 
table 1).  Because progesterone 
withdrawal may be the stimulus that 
initiates lactogenesis, administration of 
progestin-only methods shortly after 
delivery could theoretically inhibit or 
alter lactation, so some authors 
recommend waiting at least 3 days 
postpartum for administration,20 
however data for this is lacking and the 
risk of repeat pregnancy may outweigh 
the theoretical risk of altered lactation.  
In a recent review on the topic, studies 
examining the initiation of progestogen-
only methods among postpartum 
women consistently concluded that 
there were no overall, adverse effects 
on measures of breastfeeding success, 
such as duration of breastfeeding or 
time to supplementation.21  Studies also, 
importantly, showed no consistent 
adverse effects on infant health 
outcomes such as growth, gross 
development, psychomotor 
development, milestones, and general 
health.21  DMPA is commonly 
administered to US women before they 
are discharged from the hospital and 
has been recommended immediately 
postpartum by some experts.22 There 
are limited studies specifically 
examining administration of DMPA prior 
to hospital discharge in breastfeeding 
women, although existing studies have 
not shown detrimental effects on 
breastfeeding, infant growth, or 
development.21 
Some of the disadvantages of 
progestogen-only methods include the 
strict regimen of compliance required by 
progestin-only pills, prolonged and 
frequent bleeding in the etonorgestrel 
implant (Nexplanon), irregular menstrual 
bleeding and prolonged anovulation 
after discontinuation of DMPA, as well 
as weight gain and loss of bone mineral 
density (most relevant for 
adolescents).14,23  Progestin-only pills 
should be avoided in Hispanic women 
with gestational diabetes who are 
breastfeeding, because of an increased 
risk for subsequent development of type 
II diabetes.17 Contraindications include 
women with unexplained uterine 
bleeding, known breast cancer, benign 
or malignant liver tumors, or acute liver 
disease.14
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Table 1.  US MEC guidelines for contraceptive use 
Condition COC/Ring/Patch Progestin-
only pill 
DMPA Implants LNG-
releasing 
IUC 
Copper-
containing 
IUC 
Postpartum 
(non-breast-feeding) 
      
<21 days 4 1 1 1   
21 – 42 days       
    Risk factors 3 1 1 1   
    None 2 1 1 1   
>42 days 1 1 1 1   
       
Postpartum 
(breast-feeding} 
      
<21 days 4 2 2 2   
21 to <30       
    Risk factors 3 2 2 2   
    None 3 2 2 2   
30 - 42       
    Risk factors 3 1 1 1   
    None 2 1 1 1   
>42 days 2 1 1 1   
       
Postpartum 
(breast-feeding, non-
breastfeeding, 
cesarean delivery) 
      
<10 min after 
placental delivery 
    2 1 
10 min to <4 weeks 
after placental 
delivery 
    2 2 
≥4 weeks     1 1 
Peurperal sepsis     4 4 
Abbreviations: COC (combined oral contraceptive), DMPA (depot medroxyprogesterone acetate injection), LNG 
(levonorgestrel), IUC (intrauterine contraceptive.   
Key: 1 - no restriction; 2 - advantages generally outweigh theoretical risks; 3 - theoretical or proven risks usually 
outweigh the advantages; 4 - unacceptable health risk 
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Long-acting reversible contraceptive 
methods (progestogen-only methods 
including subdermal implants and 
intrauterine contraceptives) 
 
Intrauterine contraception (IUC) in the 
postpartum period warrants special 
consideration, especially given the push 
for long-acting reversible contraceptives.  
According to a recent American College 
of Obstetricians and Gynecologists 
committee opinion, the United States’ 
high unintended pregnancy rate may be 
in part, due to a relatively low use of 
long-acting reversible contraceptive 
(LARC) methods.24 Despite an increase 
in use since 1995 (when 0.8% of US 
women chose intrauterine 
contraceptive), only 3.5% of all 
reproductive age women and 5.6% of 
contraceptive-using women use an 
intrauterine contraceptive device.3 
IUCs, including the levonorgestrel-
releasing IUC and copper-containing 
IUC, are highly effective in preventing 
pregnancy, with pregnancy rates less 
than 1 per 100 woman-years.25  
Excellent candidates include women 
who desire inter-pregnancy interval of 
more than 2 to 3 years, desire long-term 
contraception but prefer to avoid 
sterilization, breastfeeding women, 
women with side effects from hormonal 
contraception, and women with prior 
birth control failures,17 though all women 
who desire highly effective 
contraception should be considered 
candidates.  In general, disadvantages 
include the uncommon side effects of 
uterine perforation, expulsion and 
discontinuation secondary to side 
effects, such as increased vaginal 
bleeding in copper-containing devices 
and decreased vaginal bleeding in 
progesterone-releasing.  Some of the 
pertinent contraindications in the 
puerperium include postpartum 
endometritis and uterine anomalies.14,17  
With appropriate counseling, the IUC 
may be used in women with a history of 
ectopic pregnancy or with risk factors for 
ectopic pregnancy.13  
While traditionally inserted 4-8 weeks 
postpartum,14,26,27 there is much interest 
in the option of immediate post-placental 
insertion.  Insertion of an IUC 
immediately after delivery is appealing 
for many reasons; the woman is known 
not to be pregnant, her motivation for 
contraception may be high, and for 
those women with limited access to 
medical care, hospitalization related to 
the delivery affords a unique opportunity 
to address the need for contraception.28  
One US study showed that of 193 
women who desired a postpartum IUC, 
35% did not return for a postpartum visit 
and only 60% actually received an IUC.  
Seven (3.6%) of these women actually 
became pregnant before they were able 
to receive an IUC.29  Other studies have 
described similar findings.28  Therefore, 
immediate postpartum insertion would 
certainly seem to improve utilization 
rates.  In a small study investigating 
postpartum insertion immediately (within 
10 minutes of placenta delivery), early 
(10 min to 48 hours postpartum), or 
interval (≥6 weeks postpartum), there 
was no difference in utilization rates 
between groups at 3 and 6 months 
postpartum.26  Another study echoed 
these results, finding that use of the 
levonorgestrel-releasing IUC at 6 
months postpartum was not different 
between women who received post-
placental or delayed insertion.30  These 
findings come despite the higher 
expulsion rates with post-placental 
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insertion, which vary from 10-27%,26,28,31 
and even 38% in one study,10 compared 
with 1-6% at one year with interval 
insertion.26,30  With close clinical follow-
up (2 weeks postpartum suggested by 
one author26) and early identification of 
expulsions so that reinsertion can occur, 
overall continuation/utilization rates at 3 
and 6 months may not be impacted.26,30  
A Cochrane review on the topic 
concluded that immediate post-partum 
insertion of IUCs appears safe and 
effective.28 According to guidelines by 
US MEC, IUCs, including the 
levonorgestrel-releasing IUD and 
copper-containing IUD, may be inserted 
postpartum, including immediately after 
delivery (categories 1 and 2) and are not 
associated with an increase in 
complications.11,13,30  The convenience 
of immediate postpartum insertion of a 
long-acting reversible contraception 
(LARC) reduces barriers to access, 
possibly outweighing the known 
disadvantage of an increased expulsion 
rate.24 
Studies reviewed by Truitt et al. did not 
find that IUCs interfere with lactation,18 
though a more recent study investigated 
the impact on breastfeeding duration by 
post-placental or delayed levonorgestrel 
intrauterine device insertion.32  These 
authors found that more women in the 
delayed group compared with the post-
placental group continued to breastfeed 
at 6–8 weeks, 3 months, and 6 months 
postpartum.32   The difference was only 
significant at 6 months.   
Approximately 14–35% of adolescent 
mothers become pregnant again within 
one year of delivery, despite intention to 
use contraception.33  We know from 
emerging evidence that increasing the 
use of contraceptive implants and 
intrauterine contraceptives (IUCs) could 
reduce repeat pregnancy among 
adolescent mothers.24  Typical use 
pregnancy rates are lower and 
continuation rates are higher for LARCs 
when compared to oral hormonal 
methods. 
In a US study of adolescent mothers, 
initiation of the six-rod contraceptive 
implant (Norplant) was the factor most 
strongly associated with repeat 
pregnancy prevention in the first 2 
postpartum years.34 Despite the 
unavailability of Norplant in the US, in a 
recent study investigating early initiation 
of the etonogestrel implant versus an 
intrauterine contraceptive, the implant 
was far more likely to be received prior 
to resumption of sexual activity than the 
IUC.33   
Lactational amenorrhea method 
Postpartum ovulation and return to 
fertility is delayed for breastfeeding 
women, to 8-10 weeks or more.14,16,17  
Lactational amenorrhea can be used as 
an effective method of contraception 
provided the woman is exclusively 
breastfeeding (on demand, day and 
night more than 5 times per day, total 
suckling duration greater than 65 
minutes, and at least 10 minutes per 
feed),35 has not resumed menses and is 
within six months of delivery.16,23,27  This 
method, when used properly, is at least 
98% effective during the first 6 months 
postpartum.16,36   Lactational 
amenorrhea becomes less effective 
after 6 months postpartum, or when 
menstrual bleeding resumes, or 
supplemental feedings are introduced. 
At which point another form of 
contraception must be initiated to 
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reliably prevent pregnancy.16   Indeed, a 
recent World Health Organization 
(WHO) study on lactational amenorrhea 
revealed that cumulative pregnancy 
rates at 12 months were as high as 
7.4%.23 Even in breastfeeding women 
whose amenorrhea extends beyond 6 
months, there is an increased tendency 
for the first ovulation to precede the first 
menstruation; thus the contraceptive 
reliability of breastfeeding diminishes 
with time. 12,14,27   
Even women planning on using 
lactational amenorrhea for postpartum 
contraception may benefit from 
anticipatory guidance and/or provision of 
contraceptives.16  One US study 
demonstrated that 8% of women who 
were planning on breastfeeding their 
newborns at the time of discharge from 
the hospital never initiated 
breastfeeding, and another 22% 
discontinued prior to the sixth 
postpartum week, putting them at risk of 
conception earlier than fully 
breastfeeding women.36 The success of 
this method is more likely to be 
achieved in highly motivated couples 
than among the general population.30   
Barrier contraception 
The use of barrier methods, including 
condoms, spermicides, and 
diaphragm/cap, have a category 1 
distinction from the US MEC for use in 
all cases postpartum, with the one 
exception of the diaphragm/cervical cap, 
which cannot be used less than 6 weeks 
postpartum due to lack of complete 
uterine involution.13  For condoms in 
particular, advantages are familiarity 
with this method, as they are used for 
contraception by 10.2% of all women in 
the United States (16.4% of women 
using some form of contraception),5 and 
protection against sexually transmitted 
infections.  Condoms are often advised 
for postpartum women who wish to 
postpone a decision about contraceptive 
therapy or sterilization until the 
postpartum visit.17 With perfect and 
typical use, pregnancy rates with 
condoms are 2% and 15% 
respectively.25 Pregnancy rates for the 
other barrier methods are substantially 
higher.25 The diaphragm has the 
disadvantages of requiring fitting by a 
physician and re-fitting is required after 
delivery due to changes in the vagina 
and cervix. Additionally, weight 
alterations and deliveries might change 
the vaginal diameter.23 In breastfeeding 
women, low estrogen levels contribute 
to vaginal dryness and tightness, 
making proper fitting of a diaphragm 
more difficult.  Proper size of the 
diaphragm should be determined at the 
6-week postpartum visit.17 The only side 
effects are vaginal wall irritation and an 
increased risk of urinary tract 
infections.23   
Natural family planning 
In women with regular cycles, for whom 
periods of abstinence are acceptable, 
natural family planning may be used17 
but is generally considered less reliable 
than combined-hormonal or progestin-
only methods, IUCs, condoms, or LAM.  
Pregnancy rates with perfect use vary 
between 1 to 9%.25 Because regular 
menses are required of this method, in 
breastfeeding women less than 6 weeks 
postpartum, both the symptom-based 
(basal body temp and cervical 
secretions) and calendar-based 
methods should not be used.  Greater 
than 6 weeks postpartum and with the 
resumption of menses, both methods 
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should be used with caution and may 
require additional counseling to ensure 
the woman is using the method 
correctly.  When at least 3 postpartum 
menses have occurred and cycles are 
regular again, a calendar-based method 
can be used.13  In non-breastfeeding 
women, neither fertility awareness 
based method should be used less than 
4 weeks postpartum.  Greater than 4 
weeks postpartum, women may use 
symptom-based methods without 
restriction or caution.  Calendar-based 
methods may be used as soon as they 
have completed three postpartum 
menses. Methods appropriate for the 
postpartum period should be offered 
before that time.13 
Sterilization 
Female sterilization is used by 27% of 
contraceptive-using women or 16.5% of 
all reproductive age women in the 
United States,5 and the puerperium is a 
convenient time for tubal ligation.  There 
are no restrictions on the 
recommendations for sterilization 
postpartum,13  and it can be performed 
at the time of cesarean section or up to 
48 hours after delivery.17  However, a 
small proportion of women regret this 
decision (1%–26% from different 
studies, with higher rates of regret 
reported by women who were younger 
at sterilization,13  which must be 
considered while counseling patients 
and likely benefits from perinatal 
counseling).  Unfortunately, only 50% of 
women who desire postpartum 
sterilization actually undergo the 
procedure and nearly one half of women 
with unfulfilled sterilization request 
become pregnant again within one 
year.37  Ensuring that sterilization is 
available in the puerperium is vital to 
helping reduce unintended pregnancy.   
Postpartum contraception education 
for patients; when to start and how to 
counsel? 
Many reasons contribute to the 
continued rate of unintended pregnancy; 
these include lack of patient education, 
ineffective contraceptive methods, 
inconsistent use of contraception, 
unplanned sexual activity, and 
contraceptive failure.38  While many of 
these factors are patient-dependent, 
contraceptive counseling is one in the 
purview of clinicians.39 The postpartum 
period represents a unique opportunity 
to provide contraception counseling.  
These women have close contact with 
providers, allowing time to discuss the 
many contraceptive options.  
Additionally, prenatal care visits offer 
additional opportunities to provide 
patients with information about 
contraception after delivery.40  
Contraceptive counseling is particularly 
important for women who have 
experienced an unwanted pregnancy 
and those at risk for repeat unintended 
pregnancy.39  For some, counseling 
during pregnancy may be the first time 
having received any education on 
contraception.39   
A CDC report summarizing the results of 
the 2004-2006 Pregnancy Risk 
Assessment Monitoring System 
(PRAMS) survey, indicated that 88.0% 
of postpartum women at risk for 
unintended pregnancy (not pregnant 
and sexually active) reported current 
use of at least one contraceptive 
method 2-9 months postpartum.  61.7% 
reported using a method defined as 
highly effective (sterilization, vasectomy, 
shot, pill, ring, patch or intrauterine 
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device), 20.0% used a method defined 
as moderately effective (condoms), and 
6.4% used less effective methods 
(including diaphragm, cervical cap, 
sponge, rhythm or withdrawal).  Women 
with no prenatal care had the lowest 
rate of use, at 76.4%.41 Yet other reports 
from demographic and health surveys in 
27 countries indicate that as many as 
2/3 of postpartum women had an unmet 
need for contraception.42   
Contraceptive education is considered 
by many to be a standard component of 
postpartum care.43  Indeed, various 
studies have indicated that between 77-
82% of women receive antenatal 
counseling regarding postpartum 
contraception,38-40 though one small 
study showed that contraception was 
discussed antenatally with only 4% of 
women.44 Postpartum discussions are 
initiated in 68-87% of women.38,40  The 
effectiveness of counseling interventions 
in reducing unintended pregnancy and 
increasing postpartum contraceptive 
use, however, has been seldom 
examined.39,43   
Of those studies investigating the topic, 
several have concluded that focused 
contraceptive counseling in the 
postpartum or antepartum period is 
effective,45-47 yet others report no impact 
on contraceptive use following 
contraception counseling48 alone, versus 
educational leaflets,49 or a short-term 
increase in contraceptive use only.40  A 
systematic review (2010) of 
contraceptive counseling interventions 
taking place in the postpartum period, 
including both short-term and multiple-
contact interventions, concluded that 
postpartum contraceptive education led 
to more contraception use and fewer 
unplanned pregnancies, though, was 
based on a limited number of studies.43  
There is evidence to suggest that 
prenatal counseling may be especially 
beneficial in increasing contraceptive 
use among women with lower levels of 
education45 or low-income women at 
high risk for repeat unintended 
pregnancy.47  Given that women with no 
prenatal care had the lowest rate of 
postpartum contraception use, at 76.4%, 
these women might benefit from more 
consultation about postpartum 
contraceptive options.41 
Several small studies have investigated 
the way in which postpartum 
contraception is approached in an 
attempt to determine which method may 
be most effective.38,46-48,50 For example, 
women who watched a video were less 
satisfied than those who had received 
counseling from a physician, though the 
video watchers were as likely to be 
satisfied as those who received a 
pamphlet.43  In a paper investigating 
patient satisfaction and the impact of 
written material about postpartum 
contraceptive decisions in 109 women, 
women in the intervention group were 
more likely to state that written material 
contributed to their ultimate choice in 
birth control.38  Additionally, those 
women receiving multi-component 
antepartum contraceptive counseling 
(consisting of counseling, a videotape 
and written material) about oral 
contraception as well as usual care 
were more likely to remain not pregnant 
at their 12 month follow-up, compared to 
those who received usual care only.47  A 
2008 randomized investigation found 
that women who were received 
postpartum contraception educational 
leaflets and 20 minute verbal counseling 
sessions were more likely to have 
started contraception (56.9% versus 
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6.3%) by the time of the postpartum 
follow-up visit, and were more likely to 
have chosen an effective method (i.e. 
oral hormonal contraceptive), compared 
to those who had not received the 
educational intervention.46  
Others have attempted to identify the 
ideal timing for postpartum 
contraception counseling, with one 
qualitative study concluding that 
counseling should take place throughout 
the antenatal care process via thorough, 
frequent and provider-initiated 
discussions using multiple teaching 
modalities.  Clearly, more work is 
needed to identify the optimal timing, 
method and content of effective 
perinatal contraceptive counseling that 
results in reduced unintended 
pregnancy rates, sustainable knowledge 
and pregnancy prevention behaviors.39 
Conclusion 
This review highlights the importance of 
utilizing the postpartum period to initiate 
contraceptive use among reproductive 
aged women, in order to decrease the 
risk of unintended pregnancy.  Ideally, 
counseling will begin early on in the 
antenatal period and include provider-
initiated discussions and a variety of 
teaching modalities.  With a little time 
and effort on the part of the physician, 
we can help patients decide on an 
effective and appropriate method of 
contraception.   
Postpartum tubal ligation is safe and 
easy to perform. 
LARC options such as the etonogestrel 
implant and intrauterine devices may be 
inserted prior to discharge and may be 
safely used in breastfeeding women. 
Combined hormonal methods such as 
the vaginal ring, patch or OCPs should 
not be used less than 21 days 
postpartum.  However, prescriptions can 
be given prior to discharge for initiation 
of these methods after 30 days 
postpartum.  
Progestin-only pills are a good option for 
women desiring an oral method and are 
appropriate for breastfeeding women. 
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